171. Wilson disease Clinical trials / Disease details
Clinical trials : 79 / Drugs : 77 - (DrugBank : 17) / Drug target genes : 6 - Drug target pathways : 30
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01472874 (ClinicalTrials.gov) | January 2010 | 11/11/2011 | Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease | Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease | Wilson Disease | Drug: Once a day Trientine | Yale University | Bausch Health Americas, Inc. | Completed | 18 Years | N/A | All | 8 | N/A | United States |